Volume 1, Issue 1 (11-2017)                   GMJ Medicine 2017, 1(1): 15-20 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Tabibzadeh Dezfuli S A, Ehsani M, Lakzaei Azar O. Carvacrol Alleivated Negative Effects of Diabetes on Inflammation and Oxidation by Modulation in Gene Expression of Inflammatory and Antioxidant System in Diabetic Rat Model. GMJ Medicine. 2017; 1 (1) :15-20
URL: http://gmjpress.de/article-1-28-en.html
1- Assistant Professor, Trauma and Emergency Medicine Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
2- Department of Microbiology, Faculty of Basic Sciences, Lahijan Branch, Islamic Azad University (IAU), Lahijan, Iran
3- Young Researchers and Elite Club, Lahijan Branch, Islamic Azad University, Lahijan, Iran
Full-Text [PDF 838 kb]   (388 Downloads)     |   Abstract (HTML)  (1132 Views)
Full-Text:   (1054 Views)
Introduction
Diabetes mellitus is a complex disease because it is a metabolic disorder that is involved with oxidation and inflammation [1]. It has been accepted that inflammation has roles in type 1 and type 2 diabetes mellitus [2, 3]. Studies have shown increased inflammatory markers in patients with diabetes [4]. Diabetic nephropathy has been known as one of the most common complications in diabetes and it is also main reason for end-stage renal disease in all over world [5]. Glucose is entered into cells in independent form of insulin and accumulated glucose increases inflammation, cell oxidation and apoptosis [6]. Pathogenesis of diabetic nephropathy could be due to binary of hemodynamic changes and excessive hyperglycemia, resulting in increased inflammation and oxidative stress [7, 8]. Increased oxidative stress and formation of pro-inflammatory cytokines happens during diabetes [9]. During Inflammation, inflammatory reactions raise levels of tumor necrosis factor-α (TNF-alpha), interlukin-1β (IL-1β) and IL-6 that interact with proteins [10]. The TNF-α has been known as an inflammatory cytokine that initiates inflammation. The IL-1β is a pro-inflammatory cytokine that calls of neutrophils into the region of infection [11]. On the other hand, oxidative stress is known to have excessive importance in diabetes. There is an imbalance between the formation and neutralization of reactive oxygen species (ROS) including highly reactive hydroxyl radicals’ superoxide anion, peroxyl radicals, singlet oxygen, peroxynitrite, and hydrogen peroxide. Enzymatic and non-enzymatic antioxidants help to treat and/or prevent the diabetes and its related complications [12]. Synthetic drugs have also been used to treat the diabetes, but its use has faced with limitations due to side effects. Plant derivations have also been used to treat the different diseases. Carvacrol, one monoterpenic phenol, that is extensively existed in some species including Origanum, Satureja, Thymbra, Thymus, and Corydothymus [13]. Carvacrol has been reported to have some pharmacological features including antioxidant [14], anti-inflammatory [15], antitumor [16], and antimicrobial [17] activity. It seems that carvacrol could improve diabetes due to its antioxidant and anti-inflammatory. We aim to introduce the carvacrol as a novel agent for treatment of diabetes. This study was thus conducted to evaluate the effects of carvacrol on inflammatory and antioxidant responses of diabetic rats.

Materials and Methods

Materials
Carvacrol was prepared from Fluka, Chemika, Sigma-Aldrich (St Quentin Fallavier, France) in purity of 95%. Streptozotocin was also prepared from Sigma-Aldrich Company. All other chemical agents used were analytical grade and prepared from standard commercial suppliers.
 
Animals
Adult male Wistar rats (220±20 g) were from the Pasture Institute, Tehran-Iran. Animals were kept in lighting program of12 h/12 h light/dark cycle. Animals had ad libitum access to food and water. All the used principles were approved by the Guide for the Care and Use of Laboratory Animals, USA, 1986.
 
Induction of diabetes
A single dose of streptozotocin (55mg/kg body weight) in 0.1M cold citrate buffer (pH 4.5) was intra peritoneal administrated to fasted rats. Control animals received citrate buffer alone. In overnight, animals consumed 5% glucose solution in order to overcome on hypoglycemia. Seventy-two hours after administration of streptozotocin, glucose was assessed by glucometer and rats with glucose concentrations>300 mg/dL were used as diabetic and studied. Animals were grouped one week after administration of streptozotocin and lasted for 7 days.
 
Experimental design
The animals (n=50) were grouped into five treatments, each comprising of ten animals, including:
Group 1: Control animals giving 0.1Mcitrate buffer (pH=4.5).Group 2: Diabetic controls.
Group 3: Diabetic animals given carvacrol (5 mg/kg Body weight/day) in neutral sterile olive oil solution oral gavage.
Group 4: Diabetic animals given carvacrol (10 mg/kg Body weight/day) in neutral sterile olive oil solution oral gavage.
Group 5: Diabetic animals given carvacrol (15 mg/kg Body weight/day) in neutral sterile olive oil solution oral gavage.
 
Evaluation of blood glucose
In day 7 of trial, the Wistar rats were fasted at over night, anaesthetized and sacrificed, by cervical dislocation. The blood samples was gathered in tubes with EDTA for investigation of plasma glucose.
 
Assessment of antioxidant activity
After killing rats, the livers were removed and washed with isotonic saline. The liver tissue was homogenated and used in 5% (w/v) potassium phosphate buffer (0.1 M, pH 7.4) by a homogenizer. The homogenate sample was then centrifuged in 16000×g for 20 min in order to remove the nuclei and cell debris. The supernatant was applied for measurement of lipid peroxidation and antioxidant activity as previously reported (18). In order to evaluate the malondialdehyde (MDA),TBARS contents of the samples were measured from a standard curve by 1,1,3,3-tetramethoxypropane.Catalase activity was measured by the molar extinction coefficient of 43.6 M-1 cm-1 for H2O2 and reported as μmol H2O2 consumed/min per milligram of protein. To evaluate the superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities, diagnostic kits of RANSOD and ANSEL (RANDOX, UK) were used and the values were reported as unit/mg protein. Protein level of the samples was assessed as reported by Bradford [19].
 
Real-time RT-PCR for IL-1β, IL-6 and TNF-α
Parts of liver samples were used to evaluate the Real-time RT-PCR for IL-1β, IL-6 and TNF-α. It was investigated as reported by Kha et al. [20]. The primers sequences were IL-1β, forward (5′-CACCTTCTTTTCCTTCATCTTTG-3′) and reverse (5′-GTCGTTGCTTGTCTCTCCTTGTA -3′), IL-6, forward (5′-TGATGGATGCTTCCAAACTG-3′) and reverse (5′-GAGCATTGGAAGTTGGGGTA-3′), TNF-α, forward (5′-ACTGAACTTCGGGGTGATTG -3′) and reverse (5′-GCTTGGTGGTTTGCTACGAC-3′) and GADPH forward (5′-GTATTGGGCGCCTGGTCACC-3′) and reverse (5′-CGCTCCTGGAAGATGGTGATGG-3′).
 
Statistical analysis
The data were analyzed by one-way analysis of variance (ANOVA) and post-hoc was conducted by the Dun­nett multiple comparison tests by the SPSS statistical package and graphs were illustrated by Graph Pad Software.
 
Results
Plasma glucoseThe data for glucose concentration are presented in Figure 1. Results showed that the plasma concentration of glucose was significantly increased in diabetic Wistar rats in comparison to control group (P<0.05). Oral administration of carvacrol could significantly decrease glucose concentration and the best responses were observed in Wistar rats given with highest levels of carvacrol (P<0.05).


Figure 1. Effects of different levels of carvacrol on plasma glucose (mg/dL) in diabetic rats
 
Antioxidant status
Our findings for effects of different levels of carvacrol on antioxidant parameters in diabetic rats are shown in Table 1. As results show, diabetic control rats showed lower levels for antioxidant enzymes and higher levels for MDA in comparison to healthy control (P<0.05). Oral administration of carvacrol could alleviate negative effects of diabetes on antioxidant status, so that we did not observe significant difference between healthy control rats and those received carvacrol in level of 15 mg/kg (P>0.05).
 
Table 1. Effects of different levels of carvacrol on antioxidant parameters in diabetic rats.
Parameters Control Diabetic Carvacrol-5 Carvacrol-10 Carvacrol-15 P-Value
SOD (U/mg protein) 15.31±1.32a 9.13±0.95d 11.15±0.98c 12.97±0.58b 14.10±0.63a ****
GPx (U/mg protein) 18.61±0.85a 11.53±0.91d 13.65±0.59c 15.21±0.72b 17.93±0.93a ****
CAT (U/mg protein) 204.21±3.25a 142.51±2.35d 158.32±3.24c 171.25±2.94b 198.56±6.51a ****
MDA (nmol/mg protein) 19.08±1.31c 26.34±1.15a 22.15±1.57b 21.45±2.13b 19.78±0.63c ****

Pro-inflammatory cytokines gene expression
Effects of different levels of carvacrol on pro-inflammatory cytokines in diabetic rats are shown in Figure 2. As results indicate diabetes increased levels of pro-inflammatory cytokines but oral administration of carvacrol especially in higher levels could alleviate effects of diabetes on pro-inflammatory cytokines.

          Figure 2. Effects of different levels of carvacrol on pro-inflammatory cytokines in diabetic rats

Discussion
Administration of streptozotocin could significantly increase levels of glucose and MDA. MDA is end product for lipid peroxidation. There is a correlation exists between lipid peroxidation and increased glucose. Manna et al. [21] showed increased lipid peroxidation in tissue that attributed it to increased blood glucose. Lipid peroxidation has been known during diabetes mellitus which is one key feature in patients with diabetes mellitus. The free radical and reactive oxygen species modulate in the different types of diseases such as diabetes. The free radicals could have important role in diabetes mellitus [22].Lipid peroxidation is known to have risks for body. Increased lipid peroxidation in the tissues of diabetic rats could be attributed to increased TBARS and hydroperoxides in the tissues [23]. With regards to increased glucose, it has been reported a positive correlation between hyperglycemia and inflammation [24]. It means that inflammation stimulates insulin resistance in the physiological level [25, 26]. Inflammation is involved in progression of diabetes and increases hyperglycemia. Oral administration of carvacrolcould significantly decreases levels of glucose. Ezhumalai et al. [27] have reported that administration of carvacrol significantly decreased level of glucose and glycosylated hemoglobin. Improved levels of glucose could be attributed to antioxidant status and inflammatory responses. Results showed that inflammatory responses and antioxidant status were significantly improved in Wistar rats fed with higher levels of carvacrol. It has been reported decreased activities of enzymatic antioxidants during diabetes, and it could be attributed to a number of deleterious effects due to the increased free radicals [28]. The SOD and CAT are known as two key enzymes that remove the toxic free radicals induced by STZ. The activities of SOD and CAT were decreased in liver tissue of diabetic rats [29]. SOD is involved in conversion of the superoxide radicals into H2O2 and molecular oxygen and also maintains the tissues from highly reactive hydroxyl radical by catalyzing the decreased hydrogen peroxides [29]. In the present study, carvacrol improved glucose level and MDA by improving level of antioxidants. Similarly, Deng et al. [30] reported that the use of carvacrol could prevent increased oxidative stress, also TNF-α andNF-κB signaling in diabetic rats [31, 32]. As mentioned earlier that diabetes is related with inflammation and thus our result shows that carvacrol decreases inflammation in diabetic rat model.
 
Conclusion
In summary, the carvacrol as novel agent could help animals with diabetes in terms of hyperglycemia, inflammation and oxidation. Since higher levels of carvacrol could significantly show anti-inflammatory and antioxidant properties, we thus recommend it to be included in the commercial preparations for prescription as therapeutic agents. 

Ethical Considerations

Compliance with ethical guidelines
There was no ethical consideration to be considered in this research.

Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Authors' contributions
All authors contributed toward data analysis, drafting and revising the paper and agreed to be responsible for all the aspects of this work.

Conflict of interest
The authors declared no conflict of interest.


References

[1] Kahraman C, Yümün G, Kahraman N,Namdar N, Cosgun S. Neutrophil-tolymphocyteratio in diabetes mellituspatients with and without diabetic footulcer. Eur J Med Sci. 2014;1(1):8-13. [DOI:10.12973/ejms.2014.102p]

[2] Colhoun H, Schalkwijk C, Rubens M, Stehouwer C. C-reactive protein in type 1diabetes and its relationship to coronary artery calcification. Diabetes Care. 2002;25:1813-1817. [DOI:10.2337/diac-are.25.10.1813] [PMID]

[3] Hayaishi-Okano R, Yamasaki Y, Katakami N, Ohtoshi K, Gorogawa S. Elevated Creactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetes. Diabetes Care. 2002; 25:1432-1438. [DOI:10.2337/diacare.25.8.1432] [PMID]

[4] Jialal I, Devaraj S, Venugopal S. Oxidative stress, inflammation and diabeticvasculopathies: The role of alpha tocopherol therapy. Free Radic Res. 2002; 36(12):1331-1336. [DOI:10.1080/1071576021000038531] [PMID]

[5] Ghaderian SB, Hayati F, Shayanpour S, Mousavi SSB. Diabetesand end-stage renal disease; a review article on new concepts. J Renal Inj Prev. 2015; 4:28-33.

[6] Magri CJ, Fava S. The role of tubular injury in diabeticnephropathy. Eur J Intern Med. 2009; 20:551-555. [DOI:10.1016/j.ejim.2008.12.012] [PMID]

[7] Giacco F, Brownlee M. Oxidative stress and diabeticcomplications. Circ Res. 2010; 107:1058-1070. [DOI:10.1161/CIRCRESA-HA.110.223545] [PMID] [PMCID]

[8] Wada J, Makino H. Inflammation and the pathogenesis ofdiabetic nephropathy. Clin Sci.2013; 124:139-152. [DOI:10.1042/CS20120198] [PMID]

[9] Schmidt AM, Yan SD, Wautier JL, Stern DM. Activation of receptor for advanced glycation end products-a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res. 1999;84:489-97. [DOI:10.1161/01.RES.84.5.489] [PMID]

[10] Romano M, Pomilio M, Vigneri S, Falco A, Chiesa PL, Chiarelli F, et al. Endothelial perturbation in children and adolescents with type 1diabetes:association with markers of the inflammatory reaction. Diabetes Care.2001;24:1674-8. [DOI:10.2337/diacare.24.9.1674] [PMID]

[11] Eo H, Lee H-J, Lim Y.  Ameliorative effect of dietary genistein on diabetes induced hyper-inflammation and oxidative stress during early stage of woundhealing in alloxan induced diabetic mice. Biochem Biophys Res Commun. 2016;478: 1021-1027. [DOI:10.1016/j.bbrc.2016.07.039] [PMID]

[12] Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacotherap. 2005; 59: 365-373. [DOI:10.1016/j.biopha.2005.07.002] [PMID]

[13] Amiri R, Akbari M. The role of carvacrol as active compound of essential oils in diabetes. Biomed J Sci  Tech Res. 2018; 11(1): DOI: 10.26717/ BJSTR.2018.11.002054. [DOI:10.26717/BJSTR.2018.11.002054]

[14] Kirimer N, Baser KHC, Tumen G. Carvacrol rich plants in Turkey. Chem Nat Comp. 1995; 31(1): 37-42. [DOI:10.1007/BF01167568]

[15] Berger JP, Akiyama TE, Meinke PT. PPARs: therapeutic targets for metabolic disease. Trends Pharmacol Sci.2005; 26(5): 244-251. [DOI:10.1016/j.tips.2005.03.003] [PMID] 

[16] Kallistratos G, Evangelou A, Agnantis N, Fasske E, Karkabounas S, et al. Enhancement of the antineoplastic effect of anticarcinogens on benzo(a)pyrene-treated Wistar rats, in relation to their number and biological activity. Cancer Lett.1994; 82:153-165. [DOI:10.1016/0304-3835(94)90006-X]

[17] Evangelou A, Kalpouzos G, Karkabounas S, Liasko R, Nonni A, et al. Dose-related preventive and therapeutic effects of antioxidants-anticarcinogens on experimentally induced malignant tumors in Wistar rats. Cancer Lett. 1997; 115:105-111. [DOI:10.1016/S0304-3835(97)04712-5]

[18] Mansouri E, Panahi M, Ghaffari MA, Ghorbani A. Effects of grape seed proanthocyanidin extract on oxidative stress induced by diabetes in rat kidney. Iran Biomed J. 2011;15:100-106.

[19] Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochem. 1976; 72:248-54. [DOI:10.1016/0003-2697(76)90527-3]

[20] Khan HA, Abdelhalim MAK, Alhomida AS, Al Ayed MS.  Transient increase in IL-1β, IL-6 and TNF-α gene expression in rat liver exposed to gold nanoparticles. Genetic Mol  Res. 2013; 12 (4): 5851-5857. [DOI:10.4238/2013.November.22.12] [PMID]

[21] Manna P, Ghosh J, Das J, Sil PC. Streptozotocin induced activation of oxidative stress responsive splenic cell signaling pathways: protective role of arjunolic acid.Toxicol Appl Pharmacol.2010: 244; 114-129. [DOI:10.1016/j.taap.2009.12.024] [PMID]

[22] Yang H, Jin X, Lam CWK, Yan SK. Oxidativestress and diabetes mellitus.Clin Chem LabMed.2011; 49: 1773-1782. [DOI:10.1515/cclm.2011.250] [PMID]

[23] Arulselvan P, Subramanian S.Ultrastructural and biochemical abnormalities in the liver of streptozotocin-diabetic rats: protective effects of Murraya koenigii. J Pharmacol Toxicol.2008; 3:190-202. [DOI:10.3923/jpt.2008.190.202]

[24] Saxena M, Modi D. Inflammation and diabetes. Interdiscip J Microinflammation. 2014;1:110.

[25] Wu T, Dorn J, Donahue R, Sempos C,Trevisan M. Associations of serum Creactiveprotein with fasting insulin,glucose, and glycosylated hemoglobin. AmJ Epidemiol. 2002;155:65-71. [DOI:10.1093/aje/155.1.65] [PMID]

[26] Fichtlscherer S, Rosenberger G, Walter D,Breuer S, Dimmeler S, Zeiher A. ElevatedC-reactive protein levels and impairedendothelial vasoreactivity in patients withcoronary artery disease. Circulation.2000;102:1000-1006. [DOI:10.1161/01.CIR.102.9.1000] [PMID]

[27] Ezhumalai M, Radhiga T, Viswanathan Pugalendi K. Antihyperglycemic effect of carvacrol in combination with rosiglitazone in high-fat diet-induced type 2 diabetic C57BL/6J mice. Mol Cell Biochem. 2014; 385: 23-31. [DOI:10.1007/s11010-013-1810-8] [PMID]

[28] Srinivasan S, Pari L. Ameliorative effect of diosmin, acitrus flavonoid against streptozotocin-nicotinamide generatedoxidative stress induced diabetic rats,” Chemico-BiolInteract. 2012; 95: 43-51. [DOI:10.1016/j.cbi.2011.10.003] [PMID]

[29] Omotayo EO, Gurtu S, Sulaiman SA, Wahab MSA,Sirajudeen KNS, Salleh MSM. Hypoglycemic andantioxidant effects of honey supplementation in streptozotocininduceddiabetic rats. Int J Vitamin Nutr Res. 2010: 80; 74–82, 2010. [DOI:10.1024/0300-9831/a000008] [PMID]

[30] Deng W, Lu H, Teng J. Carvacrol attenuates diabetes-associated cognitive deficits in rats. J Mol Neurosci.2009; 51(3): 813-819. [DOI:10.1007/s12031-013-0069-6] [PMID]

[31] Nasirian F, Dadkhah M, Moradi-Kor N, Obeidavi Z. Effects of Spirulina platensis microalgae on antioxidant and anti-inflammatory factors in diabetic rats. Diabetes Metab Syndr Obes. 2018;11:375-380. [DOI:10.2147/DMSO.S172104] [PMID] [PMCID]

[32] Mesbahzadeh B, Rajaei S.A, Tarahomi P, Seyedinia S.A, Rahmani M, Rezamohamadi F, Kakar M.A, Moradi-Kor N. Beneficial effects of spirogyra neglecta extract on antioxidant and anti-inflammatory factors in streptozotocin-induced diabetic rats. Biomolecular Concepts. 2018; 9(1): 184-189. [DOI:10.1515/bmc-2018-0015] [PMID]
Type of Study: Original Article | Subject: Pharmacology
Received: 2017/09/12 | Accepted: 2017/11/5 | Published: 2017/11/25

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2020 All Rights Reserved | GMJ Medicine